HKUMed Pioneers the World's First Hybrid Photosensitive Immunotherapy for a Breakthrough in Cancer Treatment
April 13, 2025
April 13, 2025
HONG KONG, April 13 -- The University of Hong Kong issued the following news release:
* * *
HKUMed pioneers the world's first hybrid photosensitive immunotherapy for a breakthrough in cancer treatment
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer treatment by developing a new therapy, called photosensitive hybrid y delta-T exosomes (hybrid y delta-T-Exos). This therapy targets and . . .
* * *
HKUMed pioneers the world's first hybrid photosensitive immunotherapy for a breakthrough in cancer treatment
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer treatment by developing a new therapy, called photosensitive hybrid y delta-T exosomes (hybrid y delta-T-Exos). This therapy targets and . . .